
Immunotherapy in myeloma Infosheet
This Horizons Infosheet provides information on immunotherapy, a type of treatment being used in myeloma.
This Infosheet covers key questions and topics about immunotherapy including:
- What immunotherapy is and how it works in myeloma
- Immunotherapy currently being used to treat myeloma
- New types of immunotherapies in development
- Side effects of immunotherapy
- Availability of immunotherapy in the UK
- How to take part in clinical trials with immunotherapies
- Future research
Key points you can read about in this Infosheet include:
- Immunotherapies make the body’s immune system work smarter and harder to kill myeloma cells
- Some myeloma treatments already in use are immunotherapies, for example, daratumumab and elranatamab
- New types of immunotherapies are being developed to treat myeloma. These include CAR-T cell treatments and antibody-drug conjugates
- Clinical trials and research are helping scientists to better understand how the immune system works, and ways to use it to treat myeloma

Immunotherapy Horizons Infosheet
PDF / 550KB DownloadThe Clinical trials and research collection
Discover the full libraryBrowse library content

Stay in touch
We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.











